Anti-Aging, Longevity, Life Extension and Biotechnology Information
Anti-Aging, Longevity, Life Extension and Biotechnology Information
Anti-Aging Medicine, Anti-Ageing Medicine, Antiaging Medicine
Tools » Drug Information
Related Drug Blog Entries

Agalsidase beta

MECHANISM OF ACTION ? Agalsidase beta is a recombinant form of the enzyme alpha-galactosidase-A, which is required for the hydrolysis of GL-3 and other glycosphingolipids. The compounds may accumulate (over many years) within the ...

what is agalsidase beta?

agalsidase beta is a man-made form of the naturally-occurring enzyme a-galactosidase a. a deficiency of the enzyme a-galactosidase a is called fabry disease. agalsidase beta reduces deposits of globotriaosylceramide (gl-3) in the ...

what should i avoid while taking agalsidase beta?

there are no restrictions on food, beverages, or activity during treatment with agalsidase beta.

revisable quick list of new drugs for pg entrance exams

agalsidase beta: for the treatment of fabry disease in adult patients pegvisomant: injectable formulation for the treatment of acromegaly palonosetron: for the prevention of nausea and vomiting associated with emetogenic cancer ...

Genzyme Corporation Begins Enrollment in Post-Marketing Study to ...

... has begun enrollment in a world-wide post-marketing clinical trial evaluating the efficacy and safety of treating pediatric male patients with mild Fabry disease symptoms with a low-dose regimen of Fabrazyme (agalsidase beta). ...

Early Enzyme Treatment Best in Fabry?s Disease

They prospectively followed 32 Fabry?s patients on enzyme-replacement therapy?1.0 mg/kg recombinant agalsidase beta (Fabrazyme, Genzyme) every two weeks?for three years, grouping them according to the amount of fibrosis at baseline, ...

African Pen Blank Assortment

African Pepper African plum tree Agalsidase Beta Agathosma. Check Interactions Check potential interactions between two or more drugs (complete instructions below). Bacitracin, Neomycin, Polymyxin B Topical Ointment. ...

Antioxidants Practical considerations for the

Practical considerations for the use of the new therapeutic agents marketed in the United States during 2003 are reviewed in this article: adalimumab, federal supplemental grants agalsidase beta, alefacept, alfuzosin hydrochloride, ...

Genzyme Corporation

Fabrazyme (agalsidase beta for intravenous infusion) full prescribing information. Genzyme Corporation.


Drugs By Name
Drugs By Manufacturer
Partners
The following health oriented websites are recommended:
> Drug Topics
> Health Topics
> HGH Doctor
> HGH News
> Medaus Compounding Center
> Performance Enhancing Drugs
> Personal Trainer Search
> Testosterone News

Destinations
The following on-site destinations recommended:
> Anti-Aging
> Anti-Aging Books
> Anti-Aging Feeds
Site Tree | Disclaimer
Link Index | Resources | More Resources
What is Anti-Aging, Anti-Ageing or Antiaging?
Compounding Pharmacy | HGH News | Personal Trainer Search | AAR Dir | Health Topics | OOF CMS v3.5
© Copyright 2003- Odin Metatech, Inc, All Rights Reserved. Copyright violations will be prosecuted to the fullest extent of the law. Why plagerize? Use our free RSS feeds for syndication.
We are not affiliated with the American Academy for Anti-Aging Medicine (A4M)

Powered by Odin Assemble v2.0